Everyone loves a little Andrew Lloyd Webber while strolling the Arbutus Greenway. Leo (July 23 - August 22) Your over-the-top leadership qualities are heightened this month, Leo: time to knock ...

Arbutus Biopharma (ABUS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

Is Arbutus Biopharma (ABUS) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

Vancouver Mayor Ken Sim lists the extension of TransLink’s Broadway subway from Arbutus Street to the University of B.C. as “one of the most critical transportation priorities for our region.” ...

She was born July 5, 1944, in Keyser, West Virginia, to Robert Francis Miller and Sylvia Arbutus Meyers Miller. She enjoyed participating in a bowling league and most of all, spending time and ...

A lot has happened since I last put Arbutus Biopharma Corporation (NASDAQ:ABUS) in the spotlight early last summer. This clinical stage biopharma concern. Arbutus laid off approximately 40% of its ...

Arbutus is also exiting its corporate headquarters in Pennsylvania and will terminate all in-house scientific research. The company’s focus is now an RNAi asset for hepatitis B. Arbutus Biopharma is ...

Barinthus Bio Said Initial Data From The Combination Of Imdusiran And VTP-300 Show Meaningful Reductions Of HBsAg Levels That Were Maintained Well Below Baseline.

Arbutus Biopharma Co. has a 52-week low of $2.30 and a 52-week high of $4.73. Arbutus Biopharma ( NASDAQ:ABUS – Get Free Report ) last issued its earnings results on Thursday, March 27th.

Today, a brief rundown of news involving Novo Nordisk and DBV Technologies, as well as updates from Arbutus Biopharma, Bicycle Therapeutics and CRISPR Therapeutics that you may have missed. This ...